Type: Bullish BreakoutKey Levels:Resistance: 1.1273Pivot: 1.12471Support: 1.1187Preferred Case:Prices are on bearish momentum and abiding to our descending trendline. We see the potential for further bearish momentum from our Pivot at 1.12471 in line with 78.6% Fibonacci retracement towards our Take Profit at 1.1187 in line with 100% Fibonacci retracement, 161.8% FIbonacci Projection and 61.8% Fibonacci […]
Type: Bearish ReversalKey Levels:Resistance: 1.1273Pivot: 1.12471Support: 114.158Preference:Prices are on bearish momentum and abiding to our descending trendline. We see the potential for further bearish momentum from our Pivot at 1.12471 in line with 78.6% Fibonacci retracement towards our Take Profit at 1.1187 in line with 100% Fibonacci retracement, 161.8% Fibonacci Projection and 61.8% Fibonacci extension. […]
• Gold broke daily up channel • Likely to fall to support level 1780.00 Gold continues to fall after the breakout of the support trendline of the daily up channel from the middle of December. The breakout of this up channel accelerated the active short-term correction – which started earlier from the key resistance level […]
“Facebook seems to be the antithesis of what actual consumers want their digital futures to look like,” said Subversive Capital Advisor founder Michael Auerbach. 2826 Total views 21 Total shares An exchange-traded fund linked to companies involved with the Metaverse launched on the Cboe BZX Exchange — shorting shares of Facebook’s parent company, Meta. The […]
Biogen Inc. BIIB, -0.30% shares jumped in after-hours trading Thursday following an announcement that it is selling its part of a joint venture to Samsung Electronics Co. Ltd. 005930, +1.82% Biogen has been working with Samsung Bioepis since 2012, according to a news release, and will sell its equity stake in the bio-similars venture to […]
Montréal and Toronto – The Canadian Securities Administrators (CSA) today announced amendments to National Instrument 94-101 Mandatory Central Counterparty Clearing of Derivatives (NI 94-101) and changes to Companion Policy 94-101 Mandatory Central Counterparty Clearing of Derivatives. NI 94-101 requires that certain market participants clear certain prescribed over-the-counter derivatives through a central counterparty, subject to exemptions […]